Vianco Pharma P Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 31 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Vianco Pharma P
Vianco Pharma P Ltd (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 1994 and has a history of 31 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Real Estate Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Veena Shah, Nehal Shah, Vivek Shah, and One other member serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1994PTC076247
- Company No.
076247
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vianco Pharma P?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram Shah  | Managing Director | 25-Jan-1994 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veena Shah | Director | 25-Jan-1994 | Current |
| Nehal Shah | Director | 17-Aug-1999 | Current |
| Vivek Shah | Director | 17-Aug-1999 | Current |
Financial Performance of Vianco Pharma P.
Vianco Pharma P Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vianco Pharma P?
In 2017, Vianco Pharma P had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cutting Crew Films LlpVivek Shah is a mutual person
- Manage Your Health Technologies Private Limited
Vivek Shah is a mutual person
- Sixth Generation Finance And Investment Private Limited
Vikram Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vianco Pharma P?
Unlock and access historical data on people associated with Vianco Pharma P, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vianco Pharma P, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vianco Pharma P's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.